Mwanzo500257 • BOM
add
Lupin Ltd
Bei iliyotangulia
₹ 2,356.85
Bei za siku
₹ 2,301.00 - ₹ 2,364.05
Bei za mwaka
₹ 1,774.00 - ₹ 2,376.00
Thamani ya kampuni katika soko
1.06T INR
Wastani wa hisa zilizouzwa
elfu 26.42
Uwiano wa bei na mapato
21.31
Mgao wa faida
0.52%
Ubadilishanaji wa msingi
NSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 71.68B | 24.27% |
Matumizi ya uendeshaji wa biashara | 33.93B | 18.38% |
Mapato halisi | 11.76B | 37.47% |
Kiwango cha faida halisi | 16.40 | 10.59% |
Mapato kwa kila hisa | 32.18 | 72.18% |
EBITDA | 21.20B | 52.17% |
Asilimia ya kodi ya mapato | 22.44% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 62.82B | 115.71% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 197.28B | — |
hisa zilizosalia | 456.70M | — |
Uwiano wa bei na thamani | 5.48 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 18.27% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 11.76B | 37.47% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1968
Makao Makuu
Tovuti
Wafanyakazi
24,006
